VeriMomsalicyloyl pentapeptide-33 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
Related ingredients
Frequently asked questions
- salicyloyl pentapeptide-33 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specific to salicyloyl pentapeptide‑33, and no peer‑reviewed reproductive toxicity data located. As a large peptide conjugate with no specific evidence of systemic reproductive toxicity, default hazard/mechanism scores are 0. The salicyloyl moiety raises a theoretical consideration (salicylates can have systemic effects at high exposure), but no data indicate that topical use of this peptide leads to relevant maternal exposure (sources checked: ECHA Annex VI, SCCS/CIR repositories, PubMed, PubChem, CosIng, EWG).
- salicyloyl pentapeptide-33 est-il sûr pendant l'allaitement ?
- No data on transfer into breastmilk or lactation effects were found. Given the molecule class (peptidic cosmetic ingredient with likely low dermal absorption) and absence of reproductive/lactation signals in regulatory/search sources, hazard and mechanism scores default to 0 and exposure is judged negligible for typical topical cosmetic use.
- salicyloyl pentapeptide-33 est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity data found. Because the ingredient is not demonstrably non‑absorbable and infant skin has higher surface‑area‑to‑weight and immature barrier, exposure score is increased by +1 (adult e=0 → infant e=1). No evidence specific to developmental or dermatologic hazard in 0–3 yr olds was identified.
- Comment VeriMom évalue-t-il salicyloyl pentapeptide-33 ?
- VeriMom évalue salicyloyl pentapeptide-33 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à salicyloyl pentapeptide-33 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à salicyloyl pentapeptide-33 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.